Ivabradine and Post-revascularisation Microcirculatory Dysfunction
Status:
Withdrawn
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to test whether, in patients with angina and flow limiting epicardial
coronary artery disease, pre-treatment with Ivabradine, as opposed to beta blockers, will
reduce post percutaneous coronary intervention induced microvascular dysfunction.
Phase:
Phase 4
Details
Lead Sponsor:
Liverpool Heart and Chest Hospital NHS Foundation Trust